Table 1.
Bovine gene | BTA assigna | Total hapsb | Sires phased (%)c | MAFs ≤ 0.10d | Avg r2 alle | Avg r2B.t.t.e | Valid. SNPsf | Hap SNPsg | Valid. indelsh | Valid. nsSNPsi | Region sizej (kb) | QTL or assoc.k |
PGLYRP1 | BTA18 | 8 | 95 | 2 | 0.08 | 0.14 | 7 | 7 | NA | 1 | 1.6 | Q |
TLR1 | BTA6 | 7 | 97 | 2 | 0.23 | 0.47 | 4 | 4 | NA | 1 | 1.5 | Q, A |
TLR2 | BTA17 | 17 | 93 | 11 | 0.35 | 0.60 | 31 | 30 | 1 | 13 | 3.0 | A |
TLR3 | BTA27 | 33 | 85 | 15 | 0.45 | 0.72 | 50 | 50 | ND | 3 | 10.6 | Q |
TLR4 | BTA8 | 13 | 91 | 19 | 0.14 | 0.37 | 22 | 21 | NA | 6 | 9.8 | Q, A |
TLR5 | BTA16 | 13 | 100 | 13 | 0.40 | 0.59 | 29 | 29 | 3 | 3 | 5.1 | No |
TLR6 | BTA6 | 15 | 94 | 4 | 0.27 | 0.29 | 15 | 15 | NA | 7 | 1.9 | Q |
TLR7 | BTAX | 7 | 100 | 8 | 0.27 | 0.23 | 10 | 10 | NA | 1 | 3.9 | Q |
TLR8 | BTAX | 3 | 100 | 0 | 0.93 | 0.92 | 9 | 9 | NA | 6 | 2.3 | Q |
TLR9 | BTA22 | 9 | 98 | 2 | 0.35 | 0.40 | 11 | 11 | NA | 1 | 4.3 | Q |
TLR10 | BTA6 | 19 | 91 | 22 | 0.31 | 0.45 | 28 | 28 | NA | 12 | 3.8 | Q |
Total/Avgl | 144 | 95l | 98 | 0.34l | 0.47l | 216 | 214 | 4 | 54 | 4.3l |
BTA assignments based on National Center for Biotechnology Information Refseq (Btau4.0) and radiation hybrid mapping (12).
Total haplotypes predicted from all validated markers and best-pair reconstructions (35) with probabilities ≥0.90.
Percent of sires (n = 101) exhibiting best pair phase probabilities ≥0.90. BTAX haplotypes were direct observations.
Total polymorphisms with minor allele frequencies ≤0.10.
Average intragenic r2 values estimated for adjacent SNP and indel sites for all cattle or for B. t. taurus (B.t.t.).
Numbers of putative SNPs validated as polymorphic.
Numbers of validated SNPs placed on discrete haplotypes.
Numbers of putative indels validated as polymorphic. NA = not applicable; ND = not determined.
Numbers of putative nonsynonymous SNPs validated as polymorphic.
Size of the genic region rounded to the nearest 100 bp. Kb = kilobase.
Bovine health-related QTL overlapping or proximal to investigated gene (Q), or intragenic variation associated (A) with disease susceptibility in case-control studies (25–31).
Average across all investigated genes.